Chon Hyongi, Vassilev Alex, DePamphilis Melvin L, Zhao Yingming, Zhang Junmei, Burgers Peter M, Crouch Robert J, Cerritelli Susana M
Program in Genomics of Differentiation, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda MD 20892, USA.
Nucleic Acids Res. 2009 Jan;37(1):96-110. doi: 10.1093/nar/gkn913. Epub 2008 Nov 16.
Eukaryotic RNase H2 is a heterotrimeric enzyme. Here, we show that the biochemical composition and stoichiometry of the human RNase H2 complex is consistent with the properties previously deduced from genetic studies. The catalytic subunit of eukaryotic RNase H2, RNASEH2A, is well conserved and similar to the monomeric prokaryotic RNase HII. In contrast, the RNASEH2B and RNASEH2C subunits from human and Saccharomyces cerevisiae share very little homology, although they both form soluble B/C complexes that may serve as a nucleation site for the addition of RNASEH2A to form an active RNase H2, or for interactions with other proteins to support different functions. The RNASEH2B subunit has a PIP-box and confers PCNA binding to human RNase H2. Unlike Escherichia coli RNase HII, eukaryotic RNase H2 acts processively and hydrolyzes a variety of RNA/DNA hybrids with similar efficiencies, suggesting multiple cellular substrates. Moreover, of five analyzed mutations in human RNASEH2B and RNASEH2C linked to Aicardi-Goutières Syndrome (AGS), only one, R69W in the RNASEH2C protein, exhibits a significant reduction in specific activity, revealing a role for the C subunit in enzymatic activity. Near-normal activity of four AGS-related mutant enzymes was unexpected in light of their predicted impairment causing the AGS phenotype.
真核核糖核酸酶H2是一种异源三聚体酶。在此,我们表明人类核糖核酸酶H2复合物的生化组成和化学计量与先前从遗传学研究中推断出的特性一致。真核核糖核酸酶H2的催化亚基RNASEH2A高度保守,与单体原核核糖核酸酶HII相似。相比之下,人类和酿酒酵母的RNASEH2B和RNASEH2C亚基的同源性非常低,尽管它们都形成可溶性B/C复合物,该复合物可能作为添加RNASEH2A以形成活性核糖核酸酶H2的成核位点,或作为与其他蛋白质相互作用以支持不同功能的位点。RNASEH2B亚基具有一个增殖细胞核抗原结合框,并赋予人类核糖核酸酶H2与增殖细胞核抗原的结合能力。与大肠杆菌核糖核酸酶HII不同,真核核糖核酸酶H2具有持续作用能力,并能以相似的效率水解多种RNA/DNA杂交体,提示其存在多种细胞底物。此外,在与Aicardi-Goutières综合征(AGS)相关的人类RNASEH2B和RNASEH2C的五个分析突变中,只有一个位于RNASEH2C蛋白中的R69W突变,其比活性显著降低,揭示了C亚基在酶活性中的作用。鉴于四种与AGS相关的突变酶的预测损伤会导致AGS表型,其近乎正常的活性出乎意料。